Study Examines How HDAC Inhibitors Affect Gene Expression in Feline Cells
Researchers treated two types of feline cells with four histone deacetylase (HDAC) inhibitors and analyzed the resulting transcriptomic changes using RNA sequencing. HDAC inhibitors are used in human medicine for cancers and neurological diseases, but their effects in domestic cats have been poorly characterized. The findings suggest cell-type and species-specific responses that could inform future veterinary treatments for cancer and neurological conditions in cats.
A preprint study published on bioRxiv examined how four HDAC inhibitors — panobinostat, trichostatin A, valproic acid, and vorinostat — affected gene expression in two domestic cat cell lines: kidney-derived CRFK cells and astrocyte-derived PG-4 cells. Both cell types showed upregulation of genes related to intercellular signaling, mirroring patterns seen in human cells. However, the kidney-derived CRFK cells did not show the cell cycle gene suppression typically observed in human cells, while the astrocyte-derived PG-4 cells did suppress cell cycle- and cancer-related genes, more closely resembling the human response. Notably, valproic acid — generally considered more relevant to neurological disease than cancer — suppressed more cancer-related genes in PG-4 cells than the other three inhibitors tested. The authors argue that their multi-drug, multi-cell-type comparison fills a gap even in the human literature, and that the results lay groundwork for developing HDAC inhibitor-based therapies tailored to feline veterinary medicine.
What's missing
The study was conducted entirely in vitro using two established cell lines. The long-term or dose-dependent effects of HDAC inhibitors were not assessed, and the 24-hour treatment window may not capture the full range of transcriptomic responses. As a preprint, the findings have not yet undergone formal peer review.
What different sources said
- bioRxivCenter
Transcriptomic response to histone deacetylase inhibitors in cultured feline cells
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.